ProShares Ultra Bloomberg Natural Gas

Direxion Daily FTSE China Bull 3X ETF

United States Natural Gas

Direxion Daily Semicondct Bear 3X ETF

Direxion Daily TSLA Bull 1.5X Shares

ARK Genomic Revolution Multi-Sector ETF

iShares Barclays TIPS Bond Fund

ProShares Ultra Silver

Direxion Technology Bear 3X Shares

Direxion Daily 20+ Yr Trsy Bear 3X ETF

ProShares UltraShort Bloomberg Natrl Gas

Exchange Traded Concepts Trust Range Global Coal Index ETF

Bank Of Montreal

Direxion Daily Semicondct Bull 3X ETF

iShares Ethereum Trust ETF

ProShares UltraShort Silver

Direxion Daily 20+ Yr Trsy Bull 3X ETF

Direxion Daily Technology Bull 3X ETF

iPath S&P 500 VIX ST Futures ETN

iShares MSCI India

Siyata Mobile Inc. Common Shares

Edible Garden AG Incorporated Common Stock

Eyenovia Inc. Common Stock

D-Wave Quantum Inc. Common Shares

MicroAlgo Inc. Ordinary Shares

ZK International Group Co. Ltd Ordinary Share

Pegasystems Inc. Common Stock

LOBO EV TECHNOLOGIES LTD. Ordinary shares

Green Plains Inc. Common Stock

Pony AI Inc. American Depositary Shares

Protagenic Therapeutics Inc. Common Stock

Eagle Materials Inc Common Stock

Incannex Healthcare Limited American Depositary Shares

Brainstorm Cell Therapeutics Inc. Common Stock

Dycom Industries Inc. Common Stock

NWTN Inc. Class B Ordinary Shares

Ingersoll Rand Inc. Common Stock

SCWorx Corp. Common Stock

Trip.com Group Limited American Depositary Shares

UBS Group AG Registered Ordinary Shares

Click here to get full coverage on Castle Biosciences to Acquire Previse - GlobeNewswire

Castle Biosciences to Acquire Previse  GlobeNewswire

Castle Biosciences to Acquire Previse - GlobeNewswire

Click here to get full coverage on Castle Biosciences Acquires Johns Hopkins-Backed GI Health Company Previse to Transform Cancer Detection - Stock Titan

Castle Biosciences Acquires Johns Hopkins-Backed GI Health Company Previse to Transform Cancer Detection  Stock Titan

Castle Biosciences Acquires Johns Hopkins-Backed GI Health Company Previse to Transform Cancer Detection - Stock Titan

Click here to get full coverage on Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates  Yahoo Finance

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on CASTLE BIOSCIENCES Earnings Results: $CSTL Reports Quarterly Earnings - Nasdaq

CASTLE BIOSCIENCES Earnings Results: $CSTL Reports Quarterly Earnings  Nasdaq

CASTLE BIOSCIENCES Earnings Results: $CSTL Reports Quarterly Earnings - Nasdaq

Click here to get full coverage on When Should You Buy Castle Biosciences, Inc. (NASDAQ:CSTL)? - simplywall.st

When Should You Buy Castle Biosciences, Inc. (NASDAQ:CSTL)?  simplywall.st

When Should You Buy Castle Biosciences, Inc. (NASDAQ:CSTL)? - simplywall.st

Click here to get full coverage on Castle Biosciences Inc (CSTL) Q1 2025 Earnings Report Preview: W - GuruFocus

Castle Biosciences Inc (CSTL) Q1 2025 Earnings Report Preview: W  GuruFocus

Castle Biosciences Inc (CSTL) Q1 2025 Earnings Report Preview: W - GuruFocus

Click here to get full coverage on (CSTL) On The My Stocks Page - news.stocktradersdaily.com

(CSTL) On The My Stocks Page  news.stocktradersdaily.com

(CSTL) On The My Stocks Page - news.stocktradersdaily.com

Click here to get full coverage on Castle Biosciences to buy Previse (CSTL:NASDAQ) - Seeking Alpha

Castle Biosciences to buy Previse (CSTL:NASDAQ)  Seeking Alpha

Castle Biosciences to buy Previse (CSTL:NASDAQ) - Seeking Alpha

Click here to get full coverage on Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call Transcript - Insider Monkey

Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call Transcript  Insider Monkey

Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Castle Biosciences Inc (CSTL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance

Castle Biosciences Inc (CSTL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...  Yahoo Finance

Castle Biosciences Inc (CSTL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance

Click here to get full coverage on Castle Biosciences Reports First Quarter 2025 Results - GlobeNewswire

Castle Biosciences Reports First Quarter 2025 Results  GlobeNewswire

Castle Biosciences Reports First Quarter 2025 Results - GlobeNewswire

Click here to get full coverage on Castle Biosciences Celebrates Skin Cancer Awareness Month - Stock Titan

Castle Biosciences Celebrates Skin Cancer Awareness Month  Stock Titan

Castle Biosciences Celebrates Skin Cancer Awareness Month - Stock Titan

Click here to get full coverage on Castle Biosciences (CSTL) Presents New Data on Uveal Melanoma Risk Prediction | CSTL Stock News - GuruFocus

Castle Biosciences (CSTL) Presents New Data on Uveal Melanoma Risk Prediction | CSTL Stock News  GuruFocus

Castle Biosciences (CSTL) Presents New Data on Uveal Melanoma Risk Prediction | CSTL Stock News - GuruFocus

Click here to get full coverage on DecisionDx-Melanoma Test Achieves 97.2% Accuracy in Identifying Low-Risk Melanoma Patients - Stock Titan

DecisionDx-Melanoma Test Achieves 97.2% Accuracy in Identifying Low-Risk Melanoma Patients  Stock Titan

DecisionDx-Melanoma Test Achieves 97.2% Accuracy in Identifying Low-Risk Melanoma Patients - Stock Titan

Click here to get full coverage on Castle Biosciences Inc (CSTL) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Castle Biosciences Inc (CSTL) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...  Yahoo Finance

Castle Biosciences Inc (CSTL) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on Breakthrough Melanoma Test Data Reveals Critical Survival Predictions for High-Risk Patients - Stock Titan

Breakthrough Melanoma Test Data Reveals Critical Survival Predictions for High-Risk Patients  Stock Titan

Breakthrough Melanoma Test Data Reveals Critical Survival Predictions for High-Risk Patients - Stock Titan

Click here to get full coverage on Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result - Stock Titan

Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result  Stock Titan

Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result - Stock Titan

Click here to get full coverage on CSTL Gears Up to Report Q4 Earnings: Here's What You Should Know - Yahoo Finance

CSTL Gears Up to Report Q4 Earnings: Here's What You Should Know  Yahoo Finance

CSTL Gears Up to Report Q4 Earnings: Here's What You Should Know - Yahoo Finance

Click here to get full coverage on Game-Changing Esophageal Cancer Detection: Castle Bio Partners With Top Medical Networks - Stock Titan

Game-Changing Esophageal Cancer Detection: Castle Bio Partners With Top Medical Networks  Stock Titan

Game-Changing Esophageal Cancer Detection: Castle Bio Partners With Top Medical Networks - Stock Titan

Click here to get full coverage on Castle Biosciences (CSTL) Champions Skin Cancer Awareness Initiatives | CSTL Stock News - GuruFocus

Castle Biosciences (CSTL) Champions Skin Cancer Awareness Initiatives | CSTL Stock News  GuruFocus

Castle Biosciences (CSTL) Champions Skin Cancer Awareness Initiatives | CSTL Stock News - GuruFocus

Click here to get full coverage on Castle Biosciences (CSTL) Rating Maintained as Price Target Lowered | CSTL Stock News - GuruFocus

Castle Biosciences (CSTL) Rating Maintained as Price Target Lowered | CSTL Stock News  GuruFocus

Castle Biosciences (CSTL) Rating Maintained as Price Target Lowered | CSTL Stock News - GuruFocus

Click here to get full coverage on New Data at AACR Annual Meeting Highlights Use of - GlobeNewswire

New Data at AACR Annual Meeting Highlights Use of  GlobeNewswire

New Data at AACR Annual Meeting Highlights Use of - GlobeNewswire

Click here to get full coverage on Castle Biosciences (CSTL) Receives Price Target Adjustment by Canaccord Genuity | CSTL Stock News - GuruFocus

Castle Biosciences (CSTL) Receives Price Target Adjustment by Canaccord Genuity | CSTL Stock News  GuruFocus

Castle Biosciences (CSTL) Receives Price Target Adjustment by Canaccord Genuity | CSTL Stock News - GuruFocus

Click here to get full coverage on Castle Biosciences (CSTL) to Acquire Gastrointestinal Firm Previ - GuruFocus

Castle Biosciences (CSTL) to Acquire Gastrointestinal Firm Previ  GuruFocus

Castle Biosciences (CSTL) to Acquire Gastrointestinal Firm Previ - GuruFocus

Click here to get full coverage on Castle Biosciences (CSTL) Exceeds Revenue Expectations in Q1 | CSTL Stock News - GuruFocus

Castle Biosciences (CSTL) Exceeds Revenue Expectations in Q1 | CSTL Stock News  GuruFocus

Castle Biosciences (CSTL) Exceeds Revenue Expectations in Q1 | CSTL Stock News - GuruFocus

Click here to get full coverage on Canaccord Adjusts Price Target for Castle Biosciences (CSTL) | CSTL Stock News - GuruFocus

Canaccord Adjusts Price Target for Castle Biosciences (CSTL) | CSTL Stock News  GuruFocus

Canaccord Adjusts Price Target for Castle Biosciences (CSTL) | CSTL Stock News - GuruFocus

Click here to get full coverage on Castle Biosciences (CSTL) Reports Strong Q1 2025 Revenue Growth - GuruFocus

Castle Biosciences (CSTL) Reports Strong Q1 2025 Revenue Growth  GuruFocus

Castle Biosciences (CSTL) Reports Strong Q1 2025 Revenue Growth - GuruFocus

Click here to get full coverage on Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results - Business Wire

Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results  Business Wire

Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results - Business Wire

Click here to get full coverage on Castle Biosciences Reports First Quarter 2025 Results | CSTL Stock News - GuruFocus

Castle Biosciences Reports First Quarter 2025 Results | CSTL Stock News  GuruFocus

Castle Biosciences Reports First Quarter 2025 Results | CSTL Stock News - GuruFocus

Click here to get full coverage on Castle Biosciences Ranks #30 Among Best U.S. Workplaces: 85% Employee Engagement Score - Stock Titan

Castle Biosciences Ranks #30 Among Best U.S. Workplaces: 85% Employee Engagement Score  Stock Titan

Castle Biosciences Ranks #30 Among Best U.S. Workplaces: 85% Employee Engagement Score - Stock Titan

Click here to get full coverage on Castle Biosciences to Acquire Previse | CSTL Stock News - GuruFocus

Castle Biosciences to Acquire Previse | CSTL Stock News  GuruFocus

Castle Biosciences to Acquire Previse | CSTL Stock News - GuruFocus

Click here to get full coverage on Castle Biosciences (CSTL) Adjusts 2025 Revenue Outlook | CSTL Stock News - GuruFocus

Castle Biosciences (CSTL) Adjusts 2025 Revenue Outlook | CSTL Stock News  GuruFocus

Castle Biosciences (CSTL) Adjusts 2025 Revenue Outlook | CSTL Stock News - GuruFocus

Click here to get full coverage on Castle Biosciences (CSTL) Target Price Reduced Despite Strong Re - GuruFocus

Castle Biosciences (CSTL) Target Price Reduced Despite Strong Re  GuruFocus

Castle Biosciences (CSTL) Target Price Reduced Despite Strong Re - GuruFocus

Click here to get full coverage on Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025 - Business Wire

Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025  Business Wire

Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025 - Business Wire

Click here to get full coverage on Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year - GlobeNewswire

Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year  GlobeNewswire

Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year - GlobeNewswire

Click here to get full coverage on Castle Biosciences Sets Q1 Earnings Date: Key Financial Updates Coming May 5 - Stock Titan

Castle Biosciences Sets Q1 Earnings Date: Key Financial Updates Coming May 5  Stock Titan

Castle Biosciences Sets Q1 Earnings Date: Key Financial Updates Coming May 5 - Stock Titan

Click here to get full coverage on (CSTL) Investment Report - news.stocktradersdaily.com

(CSTL) Investment Report  news.stocktradersdaily.com

(CSTL) Investment Report - news.stocktradersdaily.com

Click here to get full coverage on Notable Thursday Option Activity: CSTL, COUR, RMD - Nasdaq

Notable Thursday Option Activity: CSTL, COUR, RMD  Nasdaq

Notable Thursday Option Activity: CSTL, COUR, RMD - Nasdaq

Click here to get full coverage on Publication of Data from Prospective, Multicenter Study - GlobeNewswire

Publication of Data from Prospective, Multicenter Study  GlobeNewswire

Publication of Data from Prospective, Multicenter Study - GlobeNewswire

Click here to get full coverage on Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern - Seeking Alpha

Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern  Seeking Alpha

Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern - Seeking Alpha

Click here to get full coverage on Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Business Wire

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Click here to get full coverage on Castle Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Castle Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary  TradingView

Castle Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Click here to get full coverage on Pinning Down Castle Biosciences, Inc.'s (NASDAQ:CSTL) P/S Is Difficult Right Now - simplywall.st

Pinning Down Castle Biosciences, Inc.'s (NASDAQ:CSTL) P/S Is Difficult Right Now  simplywall.st

Pinning Down Castle Biosciences, Inc.'s (NASDAQ:CSTL) P/S Is Difficult Right Now - simplywall.st

Click here to get full coverage on Castle Biosciences to Acquire Previse - The Globe and Mail

Castle Biosciences to Acquire Previse  The Globe and Mail

Castle Biosciences to Acquire Previse - The Globe and Mail

Click here to get full coverage on Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session  Benzinga

Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Click here to get full coverage on (CSTL) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

(CSTL) Pivots Trading Plans and Risk Controls  news.stocktradersdaily.com

(CSTL) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Click here to get full coverage on Investors in Castle Biosciences (NASDAQ:CSTL) have unfortunately lost 71% over the last three years - Yahoo Finance

Investors in Castle Biosciences (NASDAQ:CSTL) have unfortunately lost 71% over the last three years  Yahoo Finance

Investors in Castle Biosciences (NASDAQ:CSTL) have unfortunately lost 71% over the last three years - Yahoo Finance

Click here to get full coverage on Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday  Benzinga

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Click here to get full coverage on New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer | CSTL Stock News - GuruFocus

New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer | CSTL Stock News  GuruFocus

New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer | CSTL Stock News - GuruFocus

Click here to get full coverage on BTIG cuts Castle Biosciences stock target to $32, keeps Buy rating - Investing.com Nigeria

BTIG cuts Castle Biosciences stock target to $32, keeps Buy rating  Investing.com Nigeria

BTIG cuts Castle Biosciences stock target to $32, keeps Buy rating - Investing.com Nigeria

Click here to get full coverage on Castle Biosciences to Participate in Upcoming Investor Conferences - Business Wire

Castle Biosciences to Participate in Upcoming Investor Conferences  Business Wire

Castle Biosciences to Participate in Upcoming Investor Conferences - Business Wire

Click here to get full coverage on Castle Biosciences to Acquire Previse - FinSMEs

Castle Biosciences to Acquire Previse  FinSMEs

Castle Biosciences to Acquire Previse - FinSMEs

Click here to get full coverage on Castle Biosciences to Release First Quarter 2025 Financial Results and Host Conference Call on Monday, May 5, 2025 - The Globe and Mail

Castle Biosciences to Release First Quarter 2025 Financial Results and Host Conference Call on Monday, May 5, 2025  The Globe and Mail

Castle Biosciences to Release First Quarter 2025 Financial Results and Host Conference Call on Monday, May 5, 2025 - The Globe and Mail

Click here to get full coverage on Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year - The Globe and Mail

Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year  The Globe and Mail

Castle Biosciences Inc (CSTL)

Price Chart

Key Statistics

Technicals

About CSTL

Latest News

Castle Biosciences to Acquire Previse - GlobeNewswire

Castle Biosciences Acquires Johns Hopkins-Backed GI Health Company Previse to Transform Cancer Detection - Stock Titan

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers